Inflammatory myopathies

Muscle-specific miRNAs in plasma and skeletal muscle of patients with idiopathic inflammatory myopathy are modulated by disease and training

Rheumatology (Oxford)Published Mechanistic study

Authors' conclusion

Lower myomiR levels in the skeletal muscle of IIM patients might indicate reduced muscle regenerative potential in IIM, which could be linked to inflammation, metabolic dysfunction, and immunosuppressive therapy. Training-induced changes in muscle and plasma myomiRs indicate an increase in the release of myomiRs, which could contribute to the adaptive response underlying the positive systemic effects of exercise in IIM.

Study context

Population
Patients with idiopathic inflammatory myopathy (IIM) and healthy controls; vastus lateralis muscle and plasma samplestraining subset n = 7
Comparison
IIM patients vs healthy controls; before vs after 6-month training in IIM
Outcome
MyomiR levels (miR-1, −206, −133a, −133b) in plasma and skeletal muscle by quantitative PCR (qPCR)
Methodological detailscase-control comparison, 6-month training intervention subset, in vitro muscle cell experiments
  • Case-control comparison
  • 6-month training intervention subset
  • In vitro muscle cell experiments

Main finding

As reported in the abstract

  • Muscle miR-133a, miR-1 and miR-206 not regulated
  • IIM vs Healthy controls: P = 0.03
  • IIM vs Healthy controls: P < 0.05

Further findings

Effect of 6-month training in IIM (n = 7)

Training lowered miR-133b in muscle while increasing miR-133b and miR-206 in plasma

In vitro myotubes

TNF, insulin, glucose and dexamethasone (individually) downregulated distinct myomiRs

Original publication

Muscle-specific miRNAs in plasma and skeletal muscle of patients with idiopathic inflammatory myopathy are modulated by disease and training. Rheumatology (Oxford). Published 7 January 2025. doi:10.1093/rheumatology/keae704

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.